{"DataElement":{"publicId":"5216252","version":"1","preferredName":"Patient Eligibility Determination Trial Screening Failure Reason","preferredDefinition":"The response that indicates the reason why candidate did not meet all the eligibility criteria defined within the study protocol.","longName":"ELIG_SCREEN_FAIL_RSN","context":"BBRB","contextVersion":"1","DataElementConcept":{"publicId":"3891913","version":"1","preferredName":"Patient Eligibility Determination Trial Screening","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Criteria to determine eligibility of patients for medical care programs and services._A process of active consideration of potential subjects for enrollment in a trial.","longName":"2660138v1.0:3891911v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2660138","version":"1","preferredName":"Patient Eligibility Determination","preferredDefinition":"A person who requires medical care.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C16960:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33DA6504-048C-121A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-26","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-26","modifiedBy":"ONEDATA","dateModified":"2007-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3891911","version":"1","preferredName":"Trial Screening","preferredDefinition":"A process of active consideration of potential subjects for enrollment in a trial.","longName":"C48262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trial Screening","conceptCode":"C48262","definition":"A process of active consideration of potential subjects for enrollment in a trial.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E60CF88E-9D17-F250-E040-BB89AD436160","latestVersionIndicator":"Yes","beginDate":"2013-09-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-11","modifiedBy":"ONEDATA","dateModified":"2013-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E60CF88E-9D28-F250-E040-BB89AD436160","latestVersionIndicator":"Yes","beginDate":"2013-09-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5215891","version":"1","preferredName":"Eligibility Failure Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"5215891v1.0","context":"BBRB","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Size of the Tumor","valueDescription":"Neoplasm Size","ValueMeaning":{"publicId":"5215894","version":"1","preferredName":"Neoplasm Size","longName":"5215894","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: The physical magnitude of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Size","conceptCode":"C25681","definition":"The physical magnitude of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFEEDBB-F844-A87A-E050-BB89AD434A38","latestVersionIndicator":"Yes","beginDate":"2016-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFEEDBB-F85D-A87A-E050-BB89AD434A38","beginDate":"2016-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-08","modifiedBy":"ONEDATA","dateModified":"2016-04-08","deletedIndicator":"No"},{"value":"Tumor is metastasis from another tissue or organ","valueDescription":"Neoplasm Other Tissue Organ Metastasis","ValueMeaning":{"publicId":"5215893","version":"1","preferredName":"Neoplasm Other Tissue Organ Metastasis","longName":"5215893","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: Different than the one(s) previously specified or mentioned.: An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.: A unique macroscopic (gross) anatomic structure that performs specific functions.  It is composed of various tissues.  An organ is part of an anatomic system or a body region.  Representative examples include the heart, lung, liver, spleen, and uterus.: The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Organ","conceptCode":"C13018","definition":"A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues.  An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFEEDBB-F821-A87A-E050-BB89AD434A38","latestVersionIndicator":"Yes","beginDate":"2016-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFEEDBB-F83A-A87A-E050-BB89AD434A38","beginDate":"2016-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-08","modifiedBy":"ONEDATA","dateModified":"2016-04-08","deletedIndicator":"No"},{"value":"Age of Majority for institution/state","valueDescription":"Institution State Age of Majority","ValueMeaning":{"publicId":"5215895","version":"1","preferredName":"Institution State Age of Majority","longName":"5215895","preferredDefinition":"An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization.: A constituent administrative district of a nation.: The age at which a minor assumes legal control over their person, actions, and decisions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Institution","conceptCode":"C41206","definition":"An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"State","conceptCode":"C87194","definition":"A constituent administrative district of a nation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Age of Majority","conceptCode":"C126362","definition":"The age at which a minor assumes legal control over their person, actions, and decisions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFEEDBB-F86B-A87A-E050-BB89AD434A38","latestVersionIndicator":"Yes","beginDate":"2016-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFEEDBB-F884-A87A-E050-BB89AD434A38","beginDate":"2016-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-08","modifiedBy":"ONEDATA","dateModified":"2016-04-08","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFEEDBB-F895-A87A-E050-BB89AD434A38","beginDate":"2016-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-08","modifiedBy":"ONEDATA","dateModified":"2016-04-08","deletedIndicator":"No"},{"value":"Participant received or is undergoing chemotherapy or radiation for any previous or current cancer","valueDescription":"Participant Current Or Prior Malignant Neoplasm Receive Chemotherapy Or Radiation Therapy","ValueMeaning":{"publicId":"5215896","version":"1","preferredName":"Participant Current Or Prior Malignant Neoplasm Receive Chemotherapy Or Radiation Therapy","longName":"5215896","preferredDefinition":"Someone who takes part in an activity.: Occurring in or belonging to the present time.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Earlier in time or order.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: To take, accept, or get something offered.: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Participant","conceptCode":"C29867","definition":"Someone who takes part in an activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"8"},{"longName":"Current","conceptCode":"C25471","definition":"Occurring in or belonging to the present time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Receive","conceptCode":"C25639","definition":"To take, accept, or get something offered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFEEDBB-F8A9-A87A-E050-BB89AD434A38","latestVersionIndicator":"Yes","beginDate":"2016-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FFEEDBB-F8C2-A87A-E050-BB89AD434A38","beginDate":"2016-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-08","modifiedBy":"ONEDATA","dateModified":"2016-04-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FFEEDBB-F7F8-A87A-E050-BB89AD434A38","latestVersionIndicator":"Yes","beginDate":"2016-04-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-08","modifiedBy":"HARTLEYG","dateModified":"2016-07-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736417","version":"1","longName":"Candidate Screening","context":"BBRB"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"Reason participant did not me","type":"Preferred Question Text","description":"Reason participant did not meet all eligibility criteria defined within the study protocol","url":null,"context":"BBRB"}],"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"303D36D3-3EFA-47B2-E050-BB89AD432621","latestVersionIndicator":"Yes","beginDate":"2016-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}